59440-79-8

Basic information

• Product Name: 1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA
• Synonyms: 1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA
• CAS NO: 59440-79-8
• Molecular Formula: C₁₈H₁₇ClN₄O₂
• Molecular Weight: 356.81
• Mol File: 59440-79-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA(59440-79-8)
• EPA Substance Registry System: 1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA(59440-79-8)

Safety Data

• Hazardous Substances Data: 59440-79-8(Hazardous Substances Data)

Usage

General Description

The chemical "1-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))-3-CHLOROPHENYLUREA" is a compound with a complex and lengthy name. It appears to contain a pyrazolin-4-yl group, a phenyl group, and a urea group. The presence of the chlorophenyl and dimethyl groups suggests that this compound may have potential applications in the field of medicinal chemistry, potentially acting on various biological targets. However, further research and analysis would be necessary to fully understand the properties and potential uses of this chemical.

Upstream product

• 83-07-8 4-amino-2,3-dimethyl-1-phenylpyrazolin-5-one 
• 104-12-1 p-chlorphenylisocyanate 

Relevant articles and documents

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

We report the discovery of potent agonists for the human formyl-peptide-like 1 receptor (hFPRL1). These compounds did not act at a closely related receptor denoted human formyl peptide receptor (hFPR) up to 10 μM concentration. Recent studies have indicat

NOVEL UREIDO - AND AMIDO-PYRAZOLONE DERIVATIVES

The present invention provides compounds of formula (I); wherein each of R1 to R4 is independently selected from hydrogen, a halogen, a substituted or unsubstituted cyclic and heterocyclic moiety, substituted or unsubstituted, linear or branched alkyl, alkyloxy, alkylcarbonyl, alkyloxycarbonyl, alkenyl, alkenyloxy, alkenylcarbonyl, alkenyloxycarbonyl, alkynyl, alkynyloxy, alkynylcarbonyl, alkynyloxycarbonyl, aryl, benzyl, arlyoxy, arylcarbonyl, aryloxycarbonyl and sulphur equivalents of said oxy, carbonyl and oxycarbonyl moieties, and A is NH, or (CH2)n, where n is preferably 0, 1 or 2. The invention also relates to methods for preparing the compounds and their uses as CCK receptor ligands and CCK antagonists.